Programme

The programme is preliminary and additional information will be added.

Final programme is expected in August 2022.

  FRIDAY 16 SEPTEMBER 20222 
TimeAbstractTitleSpeaker
11:30 Registration desk opens 
13:00-14:30 IADFS-DFSG JOINT SESSION
Closing session of IADFS – Opening session of DFSG
Chairs: Nikolaos Papanas, Greece; Venu Kavarthapu, United Kingdom
  Recent Trials and New Therapies for DFUs  Fran Game, United Kingdom
  Preventing Amputations by Preventing DFU: LEAP Back to the Future  Robert Frykberg, USA
  The Charcot Foot- Is there Consensus on Underlying Pathophysiology?  Nina Petrova, United Kingdom
  Surgical management of diabetic foot infections Venu Kavarthapu, United Kingdom
14.30-15.00 Coffee break 
15:00-15:10 DFSG WELCOMEDFSG Chairman Nikolaos Papanas
15:10-16:30 Oral presentations: Epidemiology and COVID-19; Diagnostics and ClassificationChairs: Edward Jude, Robert Frykberg
 OP01IMPACT OF COVID-19 ON DIABETIC FOOT SURGICAL TREATMENTRoberto da Ros, Italy
 OP02MORTALITY RATES AFTER LOWER EXTREMITY AMPUTATION IN BELGIUM FROM 2009 TO 2018Eveline Dirinck, Belgium
 OP03TEMPORAL TRENDS IN MAJOR, MINOR AND RECURRENT LOWER EXTREMITY AMPUTATIONS IN BELGIUM FROM 2009 TO 2018Patrick Lauwers, Belgium
 OP04RISK FACTORS FOR AMPUTATION IN PERSONS WITH DIABETES IN A SWEDISH CONTEXT – A RETROSPECTIVE COHORT DESIGNSimon Ramstrand, Sweden
 OP05ONE-YEAR HOSPITALIZATION DATA AND FOLLOW-UP OF DISCHARGED PATIENTS - OUTCOMES FROM LEVEL 3 FOOT CENTREMichal Dubsky, Czech Republic
 OP06THE COMBINATION OF ABI AND TBI IN A PRAGMATIC DESCRIPTION OF LIMB ISCHAEMIA IN PATIENTS WITH DIABETES HIGHLIGHTS THE NEED FOR SPECIALIST CARE AND DELINEATE CLINICAL OUTCOMESChris Manu, United Kingdom
 OP07VIRTUAL RAPID ACCESS VASCULAR (V-RAV) MDT FOOT CLINIC: A NEW LOCAL DELIVERY STRATEGY.Paula Grannon, United Kingdom
16:30-16:35 Short break 
16.35-17.35 Industry symposium: URGOChair: To be announced
    
17:35-17:40 Short break 
17.40-18.30 Life Time Achievement Award sessionChair: Roberto Anichini
    
    
    
18.30-19.30 Welcome Reception in the exhibition area (included in the registration fee). Please note that the event is not a dinner. 
    
  SATURDAY  17 SEPTEMBER 2022 
TimeAbstractTitleSpeaker
07:00 Diabetes Run/Walk, 5 km, open to all participants. No pre-registration necessary. 
09:00 – 10:20 Oral presentations: Foot Clinics, Organisation of Care And CharcotChairs:Nina Petrova, Sicco Bus
 OP08USING ULTRASONAGRAPHY TO ACHIEVE EARLIER DIAGNOSIS OF CHARCOT FOOT: A CASE SERIESJennifer Pallin, Ireland
 OP09MORTALITY RATES AMONG PATIENTS WITH CHARCOT'S FOOT ATTENDING MANSOURA DIABETIC FOOT CLINIC: 15 YEARS RETROSPECTIVE STUDYAhmed Albehairy, Egypt
 OP10IMPROVED MAJOR AMPUTATION RATES IN DIABETIC PATIENTS WITH ISCHAEMIC FEET COMPARED WITH NON-DIABETIC PATIENTS WITH ISCHAEMIC FEET; IMPACT OF THE MULTIDISCIPLINARY DIABETIC FOOT TEAM AND THE DIABETIC FOOT CLINIC.Aparajita Roy, United Kingdom
 OP11A LONG-TERM PROSPECTIVE COHORT STUDY OF AMPUTATION AND MORTALITY RISK FACTORS IN PATIENTS WITH DIABETIC FOOT ULCER.Roozbeh Naemi, United Kingdom
 OP12ANXIETY AND DEPRESSION AMONG ADULT PATIENTS WITH DIABETIC FOOT ULCER ATTENDING A MULTIDISCIPLINARY FOOT CLINICAbdullah Almaqhawi, United Kingdom
 OP13HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH DIABETIC FOOT ULCER ACCORDING TO  DIABETIC FOOT ULCER SCALE-SHORT FORM IN SPANISH SUBJECTSEsther Garcia Morales, Spain
 OP14STANDARD OF  CARE AUDIT IN PEOPLE WITH DIABETES ON PERITONEAL DIALYSIS HIGHLIGHTS CONTINUED LACK OF MONITORING OF FOOT RISK.Prash Vas, United Kingdom
10:20-11:00 Coffee break 
11:00-12:00 Industry Symposium 
    
    
12:05-12:40 Paul Brand Award SessionChair: Nikolaos Papanas
 Paul Brand Award OralTHE INFLUENCE OF WEAR AND TEAR OF THERAPEUTIC FOOTWEAR IN PATIENTS IN REMISSION. A 5-YEARS FOLLOW-UP STUDYMateo López Moral, Spain
12:40-13:40 Lunch break 
13:40-14:40 Poster discussion I, 4 parallel sessions 
13:40-14:40 Poster Session A: Top 5 postersChairs: Anna Trocha, Frances Game
 PP01OUTCOMES FROM DAY CASE SURGERY OF A SINGLE PODIATRIC SURGEON DURING THE COVID-19 PANDEMIC FROM A MULTIDISCIPLINARY DIABETIC FOOT CLINICJolyon Dales, United Kingdom
 PP02WOUND BLUSH AS AN INDICATOR FOR LIMB SALVAGE AMONG PEOPLE WITH TYPE 2 DIABETES WITH PERIPHERAL ARTERIAL DISEASE: AN OBSERVATIONAL STUDY FROM SOUTH INDIASukanya Nachimuthu, India
 PP03ANEMIA AT ADMISSION IS NOT ASSOCIATED WITH A WORSE PROGNOSIS IN DIABETIC FOOT INPATIENTS.Elisabetta Iacopi, Italy
 PP04AMBULATORY NEGATIVE PRESSURE WOUND THERAPY IN PATIENTS WITH DIABETIC FOOTRobert Bem, Czech Republic
 PP05NOVEL TOPICAL ESMOLOL HYDROCHLORIDE FOR DIABETIC FOOT ULCER: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE PHASE 1/2 STUDYAshu Rastogi, India
13:40-14:40 Poster Session B: BiomechanicsChair: To be announced
 PP06PREDICTIVE VALUES OF FOREFOOT PLANTAR PRESSURE ASSESSMENT TO IDENTIFY A REULCERATION EVENT IN PATIENTS AT HIGH RISKMarta García-Madrid Martín de Almagro, Spain
 PP07CLINICAL EFFICACY OF A 3D FOOT SCANNER APP FOR THE FITTING OF THERAPEUTIC FOOTWEAR IN PERSONS WITH DIABETES IN REMISSION: A RANDOMIZED AND CONTROLLED CLINICAL TRIAL.Raúl Molines Barroso, Spain
 PP08DIFFERENT PATTERN OF FOOT STRUCTURAL CHANGES BETWEEN DIABETIC AND NON DIABETIC PATIENTS AS A CONSEQUENCE OF WEIGHT LOSS IN SEVERE OBESITYElisabetta Iacopi, Italy
 PP09THE JOINT-VENTURE OF DIABETES AND OBESITY ON HUMAN WALKING STRATEGY.Elisabetta Iacopi, Italy
 PP10THE ACCURACY OF BIOMECHANICAL MODELS TO ESTIMATE CUMULATIVE PLANTAR TISSUE STRESS IN PEOPLE WITH DIABETES AT HIGH RISK OF FOOT ULCERATIONJaap van Netten, Netherlands
 PP11THE EFFECTIVENESS OF AN AFFORDABLE TOA UZITO (OFFLOADING) DEVICE FOR IMPROVING PLANTAR DIABETIC FOOT ULCER OUTCOMES IN THE DEVELOPING WORLD.Zulfiqarali G. Abbas, Tanzania
 PP12FIF!-MOBIL, A NEW, IRREMOVABLE OFFLOADING METHOD DESIGNED FOR WALKINGMira Mertens, Germany
13:40-14:40 Poster Session C: Wound healing part 1Chair: Vilma Urbančič Rovan 
 PP13THE IFOOT-PROJECT - A COMPLEX INTERVENTION INTEGRATING E-HEALTH TO PRESERVE MOBILITY OF PEOPLE WITH DIABETIC PLANTAR PRESSURE ULCERSDirk Hochlenert, Germany
 PP14FREEZE-DRIED HUMAN AMNIOTIC MEBRANE ALLOGRAFT IN THE THREATMENT OF DIABETIC FOOT ULCERMiroslav Koliba, Czech Republic
 PP15LYOPHILIZED ALLOGRAFT OF THE HUMAN AMNIOTIC MEMBRANE IN THE TREATMENT OF PATIENTS WITH DIABETIC FOOT ULCERSEmil Martinka, Slovakia
 PP16DGH EXPERIENCE OF USING COLD PLASMA MEDICAL DEVICE AS AN ADJUNCT THERAPY TO ANTIMICROBIALS IN TREATING CHRONIC NON HEALING INFECTED DIABETIC FOOT ULCERS.Jemma Cruickshank, United Kingdom
 PP17THE IMPACT OF TOTAL CONTACT CASTING (TCC) IN CONJUNCTION WITH BOHLER IRON ON A COHORT OF PATIENTS WITH CHRONIC NON HEALING DIABETIC FOOT ULCERS.Mary Gray, United Kingdom
 PP!8OUTCOMES OF TREATING HIND FOOT ULCERS AT A UK DIABETES FOOT CLINICHannah Bond, United Kingdom
 PP19EFFECTIVENESS OF THE FAST-TRACK PATHWAY FOR THE MANAGEMENT OF PATIENTS WITH DIABETIC FOOT THROUGH THE NETWORK BETWEEN SECOND AND THIRD LEVEL CENTERSMichela Di Venanzio, Italy
 PP20HEALING OF A 10-YEAR-LASTING CHRONIC DIABETIC NEUROPATHIC DEFECT USING A DEHYDRATED   HUMAN AMNIOTIC MEMBRANE  ALLOGRAFT - A CASE REPORTJohana Venerova, Czech Republic
 PP21ANTIPHOSPHOLIPID SYNDROME (APS) - A CLINICAL POSSIBILITY FOR THE ISCHAEMIC FOOTPeter Reston, United Kingdom
13:40-14:40 Poster Session D: InfectionChair: To be announced
 PP22INFRARED THERMOGRAPHY FOR MONITORING SEVERITY AND TREATMENT OF DIABETIC FOOT INFECTIONSKor Hutting, Netherlands
 PP23DIAGNOSIS OF OSTEOMYELTITIS: INVESITGATION OPTIMISATION IN DIABETIC FOOT ULCERS – THE DOMINO-DFU STUDYDavid Russell, United Kingdom
 PP24THE QUALITY OF LIFE AND COST BENEFITS OF DOMICILIARY 24-HOUR PIPERACILLIN/TAZOBACTAM 13.5G INFUSION IN PATIENTS WITH DIABETIC FOOT DISEASEMichael Pierides, United Kingdom
 PP25POSSIBLE ADVANTAGES OF BIOACTIVE GLASS IN THE TREATMENT OF SEPTIC OSTEOARTHRITISIgor Frangež, Slovenia
 PP26WHICH FACTORS INFLUENCE IN HEALING TIME IN PATIENTS WITH DIABETIC FOOT OSTEOMYELITIS?Aroa Tardáguila García, Spain
 PP27DALBAVANCIN: DOES COSTING MORE ACTUALLY COST LESS?Joanna Tanner, United Kingdom
 PP28PERFORMANCES OF TLC-AG DRESSINGS* ON DIABETIC FOOT ULCERS AT  RISK OR WITH CLINICAL SIGNS OF LOCAL INFECTION:  RESULTS OF A MULTICENTRE, PROSPECTIVE, OBSERVATIONAL STUDYMichael Dietlein, Germany
 PP29DOES MULTIDRUG-RESISTANT ORGANISM IMPACT IN CLINICAL OUTCOME OF DIABETIC FOOT ULCERS OSTEOMYELITIS TREATED SURGICALLY?Esther Garcia Morales, Spain
 PP30IS TAZOCIN INDUCED AKI A GENUINE PROBLEM IN DIABETIC FOOT INFECTIONS?Joanne Patterson, United Kingdom
 PP31EVALUATION OF THE DIAGNOSTIC ACCURACY OF THE COMBINATION OF BONE PROBE, PLAIN RADIOGRAPHY AND ERYTHROCYTE SEDIMENTATION RATE IN THE DIAGNOSIS OF DIABETIC FOOT OSTEOMYELITIS.Irene Sanz Corbalán, Spain
14.45-15.00 Industry symposium: Mölnlycke 
    
15:05-15:20 Industry Symposium: BioHealing 
    
15:25-15:55 Coffee break 
15:55-16:20 Update from the DFSG Research Group: Prevention of the First UlcerChairs:Anna Trocha, Sicco Bus
    
16:25-17:50 Oral Award Presentations - Top 5 abstractsChairs: José Luis Lazaro Martinez, Nikolaos Papanas
 Award Oral 1AGREEMENT BETWEEN RADIOGRAPHIC AND NON-CONTRAST MAGNETIC RESONANCE IMAGING IN REPORTING BONE DAMAGE IN ACUTE CHARCOT NEURO-OSTEOARTHROPATHYNina Petrova, United Kingdom
 Award Oral 2CONTINUOUS, HIGH-PRESSURE FEEDBACK ‘ALERT’ THERAPY REDUCES HIGH PRESSURE AT SPECIFIC PLANTAR SITES ACROSS THE ‘HIGH-RISK’ DIABETIC FOOT.Caroline Abbott, United Kingdom
 Award Oral 3BELOW-THE-ANKLE ARTERIAL DISEASE: A NEW MARKER OF CORONARY ARTERY DISEASE IN PATIENTS WITH DIABETES AND FOOT ULCERSErmanno Bellizzi, Italy
 Award Oral 4THE DESIGN OF AN INTEGRATED PERSONALIZED ASSISTIVE DEVICES APPROACH TO REDUCE FOOT ULCER RECURRENCE IN DIABETESLisa Vossen, Netherlands
 Award Oral 5COMPARISON OF DIFFERENT METHODS TO ASSESS THERAPEUTIC FOOTWEAR USE AMONG PEOPLE WITH DIABETESGustav Jarl, Sweden
17:55-18:10 Award Ceremony 
  Winners of the Oral Award and Poster Prize are announced 
18:10-18:40 Business Meeting and Assembly
For members of DFSG only
 
19:30-24:00 Conference Dinner


Adress: TBA
 
    
  SUNDAY 18 SEPTEMBER 2022 
TimeAbstractTitleSpeaker
08:30-09:30 Poster discussion II, 4 parallel sessions 
08:30-09:30 Poster Session E: Wound Healing part 2Chair: Esther Garcia Morales
 PP32THE ACCUMULATING EVIDENCE SUPPORTING THE USE OF CYCLICAL PRESSURIZED TOPICAL OXYGEN THERAPY FOR HEALING CHRONIC WOUNDSMatthew Garoufalis, United States
 PP33RAPID IMPROVEMENT OF WOUND HEALING AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH DFUS TREATED WITH TLC-NOSF POLYABSORBENT DRESSINGS* - RESULTS FROM A PROSPECTIVE, MULTICENTRE REAL-LIFE STUDYClaas Lüdemann, Germany
 PP34EFFECTIVENESS OF SUCROSE OCTASULFATE DRESSING IN THE TREATMENT OF NEURO- ISCHAEMIC DIABETIC FOOT HEEL ULCERS: A RETROSPECTIVE SINGLE ARM STUDYSerge Bohbot, France
 PP35CLINICAL AND HISTOPATHOLOGICAL EFFICACY OF DAILY APPLICATION OF NEGATIVELY CHARGED POLYSTYRENE MICROSPHERES VERSUS THREE TIMES APPLICATION IN HARD-TO-HEAL DIABETIC FOOT ULCERS: A RANDOMIZED BLINDED CONTROLLED CLINICAL TRIAL.Yolanda García Álvarez, Spain
 PP36THE EFFECT OF TRANSCUTANEOUS CO2 ON CHRONIC WOUND HEALING, MICROCIRCULATION AND DIABETIC SYMMETRICAL NEUROPATHY IN DIABETIC PATIENTSIgor Frangež, Slovenia
 PP37THE POWER OF TWO2: THE HEALTH AND ECONOMIC BENEFITS OF THE REAL WORLD USE OF CYCLICAL PRESSURIZED TOPICAL OXYGEN THERAPY IN THE HEALING OF DIABETIC FOOT ULCERSMatthew Garoufalis, United States
 PP38COMPRESSION BANDAGE ---- IS IT A BOON FOR VENOUS ULCERS IN DIABETICS??Sangeetha Kalabhairav, India
08:30-09:30 Poster Session F: Epidemiology and COVID-19Chair: Luigi Uccioli
 PP39CONTINUATION OF CARE DESPITE COVID-19 PANDEMIC RESULTS IN STABLE OUTCOMES: A NATIONWIDE COHORT STUDY IN BELGIUMAn-Sofie Vanherwegen, Belgium
 PP40IMPACT OF THE COVID PANDEMIC ON DIABETES FOOT CARE SERVICE IN A TERTIARY SETTINGSheena Thayyil, United Kingdom
 PP41TRENDS IN LOWER-LIMB MAJOR AND MINOR AMPUTATION IN PEOPLE WITH DIABETES IN THE FRIULI VENEZIA GIULIA ( NORTHERN ITALY ) DURING THE COVID-19 PANDEMICCesare Miranda, Italy
 PP42THE IMPACT OF COVID-19 PANDEMIC IN AMPUTATIONS OF DIABETIC PATIENTS IN VASCULAR DEPARTMENTStavroula-Panagiota Lontou, Greece
 PP43LOWER LIMB AMPUTATIONS IN SLOVENIA BETWEEN 2015 AND 2019Vilma Urbancic-Rovan, Slovenia
 PP44CLINICAL CHARACTERISTICS, MANAGEMENT AND OUTCOME OF HOSPITALIZED PATIENTS WITH DIABETIC FOOT PROBLEMS  IN VASCULAR SURGERY DEPARTMENTStavroula-Panagiota Lontou, Greece
 PP45MICROBIOLOGICAL DATA AND COMORBIDITIES OF HOSPITALIZED PATIENTS WITH DIABETIC FOOT PROBLEMS  IN VASCULAR SURGERY DEPARTMENTStavroula-Panagiota Lontou, Greece
08:30-09:30 Poster Session G: Foot Clinics, Orthopaedic Surgery and RevascularizationChair: Prashnath Vas
 PP46CAN THE DURATION OF HOSPITALIZATION BE RELATED TO MAJOR OR MINOR AMPUTATIONS IN PATIENTS WITH DIABETES?Alexandra Jirkovská, Czech Republic
 PP48EVALUATION OF EXTERNAL AUDITS OF FOOT CLINICS IN CZECH REPUBLICPavlina Pithova, Czech Republic
 PP49IMPACT OF FLASH GLUCOSE MONITORING ON GLYCAEMIC CONTROL IN HIGH RISK DIABETIC FOOT PATIENTS.Edward Jude, United Kingdom
 PP50ASSESSING DIABETIC PERIPHERAL NEUROPATHY IN PERSONS WITH DIABETES AND FOOT ULCERS HAS LIMITED USE IN CLINICAL PRACTICELouise Barth, Denmark
 PP51THE USE OF A TOTAL CONTACT CASTING (TCC) ENHANCED WITH THE BÖHLER IRON TO PROMOTE HEALING AND AID SURGICAL INTERVENTION FOR CHRONIC DIABETIC FOOT ULCERS (DFU).Jacqueline Mildred, United Kingdom
 PP52MINIMUM INVASIVE TECHNIQUE IS USEFUL OF DIABETIC FOOT DEFORMITYYuta Terabe, Japan
 PP53FOOT REVASCULARIZATION AVOIDS MAJOR AMPUTATION IN PATIENTS WITH ISCHAEMIC DIABETIC FOOT ULCERSMarco Meloni, Italy
08:30-09:30 Poster Session H: Basic and clinical science, Classification and OtherChair: To be announced
 PP54IMPROVED OUTCOMES IN PATIENTS WITH DIABETIC FOOT ULCERS DESPITE OF DIFFERENCES IN BASELINE CHARACTERISTICSAfram Akturk, Netherlands
 PP55FIRST ULCER INCIDENCE IN CORRELATION TO PAIN PERCEPTION IN NEWLY PRESENTING DIABETIC PATIENTS WITH NEUROPATHY IN A PROSPECTIVE OBSERVATIONAL STUDY.Anna Katharina Trocha, Germany
 PP56ASSESSMENT OF THE EFFECTIVENESS OF THE CURRENT NUTRITIONAL SUPPORT IN REACHING THE DAILY ENERGY REQUIREMENTS OF PATIENTS HOSPITALIZED FOR A DFUAnne-Sophie Baart, Belgium
 PP57A NEW DFU DESCRIPTION FOR PRIMARY CARE: A SIMPLE AND SMART MODEL TO ASSESS WOUND SEVERITY AND AVOID LATE REFERRALJuan Pedro Sanchez Rios, Spain
 PP58SKIN ADVANCED GLYCATION END PRODUCTS AS INDEPENDENT DETERMINANTS OF DISTAL SENSORIMOTOR POLYNEUROPATHY IN SUBJECTS WITH TYPE 2 DIABETES MELLITUSStella Papachristou, Greece
 PP59RESULTS OF A UK RESEARCH PRIORITY SETTING PARTNERSHIP IN DIABETIC FOOT DISEASEDavid Russell, United Kingdom
 PP60A NOVEL ADJUNCT TO SIMULATION TO ENHANCE LEARNINGSam Little, United Kingdom
 PP61AN APPLICATION OF SNM FOR THE PROMOTION OF PHYSICAL ACTIVITY IN PATIENTS AT RISK OF DIABETIC FOOT.Piergiorgio Francia, Italy
 PP62FOOT EXAMINATION IN PEOPLE PRESENTING WITH FALLS, WITH AND WITHOUT DIABETESEdward Jude, United Kingdom
09:35-10:35 Industry symposium 
    
10:35 – 11:10 Coffee break 
11:10-12:20 Oral presentations: Biomechanics and Orthopaedic surgeryChairs: Enrico Brocco,  Anne Rasmussen
 OP15VIBRATING INSOLES: INVESTIGATING THEIR INFLUENCE ON DYNAMIC BALANCE AND GAIT QUALITY IN PEOPLE WITH DIABETIC PERIPHERAL NEUROPATHYGiorgio Orlando, United Kingdom
 OP16CUMULATIVE PLANTAR TISSUE STRESS AND ITS ASSOCIATION WITH FOOT ULCER RECURRENCE IN PEOPLE WITH DIABETESChantal M. Hulshof, Netherlands
 OP17DIABETIC FOOT ULCER PREVENTION THROUGH FOOTWEAR SENSING TECHNOLOGY: A LITERATURE REVIEWGeorge Dafoulas, Greece
 OP18FLEXOR TENDON TENOTOMY TREATMENT OF THE DIABETIC FOOT:  A MULTICENTER RANDOMIZED CONTROLLED TRIALJonas Askø Andersen, Denmark
 OP19HOW DO WE OBJECTIVELY ASSESS DIABETES FOOT SURGERY: A SYSTEMATIC REVIEW & DOMAIN DRIVEN ANALYSIS TO IDENTIFY CRITICAL DIABETES FOOT SPECIFIC OUTCOMES.Raju Ahluwalia, United Kingdom
 OP20META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS TESTING THE EFFECT OF AT-HOME FOOT TEMPERATURE MONITORING AND REDUCTION OF AMBULATORY ACTIVITY IN RESPONSE TO HOTSPOTS ON THE INCIDENCE OF DIABETES-RELATED FOOT ULCERSWouter Aan de Stegge, Netherlands
12.25-13:00 Update from the DFSG Research Group: Charcot FootChairs: Frances Game, Alexandra Jirkovska
    
    
13:00-14:00 Lunch break 
14:00-15:10 Oral presentations: Wound healing & Basic and clinical scienceChairs: Anna Korzon-Burakowska
 OP21TISSUE AVAILABILITY OF INTRAVENOUSLY ADMINISTERED ANTIBIOTICS IN PATIENTS WITH INFECTED DIABETIC FOOT ULCERS IN THE CONTEXT OF PAD AND MICROCIRCULATION STATUS – PILOT DATA (DFIATIM STUDY)Vladimira Fejfarova, Czech Republic
 OP22THE MAJOR AMPUTATION RISK STRATIFICATION USING DIABETIC FOOT ULCER CLASSIFICATIONS IN PATIENTS WITH CRITICAL LIMB-THREATENING ISCHEMIA AFTER AUTOLOGOUS STEM CELL THERAPYJitka Husakova, Czech Republic
 OP23ULTRASOUND-ASSISTED WOUND (UAW) DEBRIDEMENT IN THE TREATMENT OF DIABETIC FOOT ULCER: A SYSTEMATIC REVIEW AND META-ANALYSISFrancisco Javier Álvaro Afonso, Spain
 OP24DOES THE ADDITION OF ANTISEPTIC IRRIGATION WITH INSTALLATION IMPROVE OUTCOMES OF THE DIABETIC FOOT COMPARED TO TRADITIONAL NEGATIVE PRESSURE WOUND THERAPY? A SYSTEMATIC REVIEW AND META-ANALYSISArthur Tarricone, United States
 OP25MICROCIRCULATION IMPROVEMENT IN DIABETIC FOOT PATIENTS AFTER THE TREATMENT WITH SUCROSE OCTASULFATE IMPREGNATED DRESSINGSJosé Luis Lazaro Martinez, Spain
 OP26COST-EFFECTIVENESS OF TLC-NOSF DRESSINGS IN THE MANAGEMENT OF DFUS, CONSIDERING DIFFERENT HEALTH CARE SYSTEMS WORLDWIDE: AN OVERVIEW ANALYSISChris Manu, United Kingdom
15:10-15:15 Closing of DFSG 2022DFSG Chairman, Nikolaos Papanas
15:15-16:00 Farewell reception